Comparative study of the harmonization of pharmaceutical regulations in the western and central sub-regions of Africa

  • AMARI Antoine Serge
  • Yavo J.C.
  • Yessibi Pola E
  • Pabst Jean-Yves
DOI https://doi.org/10.22270/ijdra.v6i4.288

Abstract

The harmonization of pharmaceutical regulations in Africa aims to offer States a coherent body of texts and practices by combining limited resources. The objective of this study was to describe policies to harmonize pharmaceutical regulations in West and Central Africa in order to highlight similarities and disparities. The methodology used consisted of visiting the historical stages of the process in the two regions and comparing the preferred methodological approaches as well as the achievements obtained. It emerges from this work that if choices, guided by the health priorities of the regions in question, have led the actors to favor, depending on the sub-region, certain areas of pharmacy rather than others, in terms of harmonization, reality the aim pursued is the same namely the protection of public health by the availability of medicines safely and cheaply. It is hoped that cooperation not only between the two sub-regions but also with other pharmaceutical regulatory systems will optimize the processes initiated for better protection of public Health.

Keywords: Pharmaceutical Regulation - Harmonization - West Africa - Central Africa

Downloads

Download data is not yet available.

References

1. Anyinefa A. Descriptive study on the harmonization of pharmaceutical regulations in Africa: the case of the West African Monetary and Economic Union (UEMOA), UFR SP; July 2015.
2. Benfeddoul A. ICH Drug Registration Standards: Part of an Efficiency Scheme for Developing Countries. Thesis Pharmacy. University of Bordeaux; 2003
3. Economic and Monetary Community of Central Africa (CEMAC). Regulation No. 02/13 / ECAC-OCEAC-CM adopting guidelines on the supply of essential drugs
4. Economic and Monetary Community of Central Africa (CEMAC). Regulation No 03/13 / ECAC-OCEAC-CM adopting the guidelines on pharmacovigilance
5. Economic and Monetary Community of Central Africa (CEMAC). Regulation No. 04/13 / ECAC-OCEAC-CM adopting the pharmaceutical inspection procedure manual
6. Economic and Monetary Community of Central Africa (CEMAC). Regulation No. 05/13 / ECAC-OCEAC-CM on the standard for the harmonization of approval procedures for medicinal products for human use
7. Economic and Monetary Community of Central Africa (CEMAC). Regulation No. 07/17-UEAC-OCEAC-CM-31 adopting the 2016-2020 operational action plan for the coordinated fight against counterfeit medicines and illicit drug circuits in the CEMAC zone; 2016
8. Directive 2001/83 / EC establishing a Community Code relating to medicinal products for human use; OJEC of 28 Nov 2001.
9. DE LA VOLPILIERE ALEXANDRE, Establishment of the Regulatory Harmonization Process in Central Africa (CEMAC / OCEAC). Seminar on Pharmaceutical Policies Experts Francophones, WHO: Geneva; Sept 2015.
10. OUEDRAOGO SAFIATOU, OUATTARA, Situation of the harmonization of the pharmaceutical regulation within the UEMOA. WHO: Geneva; 14 to 18 June 2010
11. West African Economic and Monetary Union (UEMOA). Regulation No. 02/2005 / CM / UEMOA on the Harmonization of Pharmaceutical Regulations in UEMOA Member States; 2005
12. West African Economic and Monetary Union (UEMOA). Regulation No. 01/2006 / CM / UEMOA establishing and operating procedures of a veterinary committee within UEMOA
13. West African Economic and Monetary Union (UEMOA) Regulation No. 02/2006 / CM / UEMOA establishing Community procedures for the authorization of placing on the market and the surveillance of veterinary drugs and establishing a regional committee for veterinary medicinal products; 2006
14. West African Economic and Monetary Union (UEMOA). Regulation No. 03/2006 / CM / UEMOA establishing fees in the field of veterinary medicinal products within WAEMU; 2006
15. West African Economic and Monetary Union (UEMOA). Regulation No. 06/2010 / CM / UEMOA on the procedures for the approval of pharmaceutical products for human use in WAEMU member states; 2010
16. West African Economic and Monetary Union (WAEMU). Decision No. 06/2010 / CM / UEMOA
adopting guidelines for the approval of food supplements in UEMOA Member States; 2010
17. West African Economic and Monetary Union (UEMOA). Decision No. 07/2010 / CM / UEMOA adopting guidelines for the approval of cosmetic products in UEMOA Member States; 2010
18. West African Economic and Monetary Union (UEMOA) Decision No. 08/2010 / CM / UEMOA adopting Guidelines for the Good Manufacturing Practices for Pharmaceutical Products for Human Use in UEMOA Member States; 2010
19. West African Economic and Monetary Union (UEMOA) Decision No. 09/2010 / CM / UEMOA adopting Guidelines for Good Practice in the Distribution and Importation of Pharmaceutical Products for Human Use in UEMOA Member States; 2010
20. West African Economic and Monetary Union (UEMOA). Decision No. 10/2010 / CM / UEMOA adopting guidelines for the control of information and advertising of medicines to professionals in UEMOA Member States; 2010
Statistics
413 Views | 668 Downloads
How to Cite
Antoine Serge, A., Y. J.C., Y. Pola E, and P. Jean-Yves. “Comparative Study of the Harmonization of Pharmaceutical Regulations in the Western and Central Sub-Regions of Africa”. International Journal of Drug Regulatory Affairs, Vol. 6, no. 4, Dec. 2018, pp. 46-51, doi:10.22270/ijdra.v6i4.288.
Issue
Vol 6 No 4 (2018): VOLUME 6, ISSUE 4, 2018
Section
Review
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.

I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.

Download link for COPYRIGHT FORM